Rejuvenation Technologies secures investment from Jetstream Venture Fund. The amount of the investment was not disclosed.
Round Type
Venture
Mountain ViewBiotechnologyHealth CareTherapeuticsInvestors
Description
Rejuvenation Technologies, a Mountain View, CA-based provider of targeted mRNA therapies, received an investment from Jetstream Venture Fund. The company intends to use the funds to expand operations and enhance R&D efforts. Led by CEO John Ramunas, Rejuvenation Technologies develops therapies aimed at reversing cellular aging. Their platform targets severe age-related diseases through innovative mRNA delivery.
Quick answer
Rejuvenation Technologies raised an undisclosed amount in a funding round, dated September 24, 2026. Investors: Jetstream Venture Fund. Rejuvenation Technologies is based in Mountain View, California, United States.
- How much did Rejuvenation Technologies raise?
- Rejuvenation Technologies raised an undisclosed amount in a funding round on September 24, 2026.
- Who invested in Rejuvenation Technologies?
- Jetstream Venture Fund is named as investors in this round.
- What does Rejuvenation Technologies do?
- Rejuvenation Technologies is a longevity startup company based in Mountain View, California.
- Where is Rejuvenation Technologies based and how big is it?
- Rejuvenation Technologies is based in Mountain View, California, United States. Fundz records about 20 employees.
- Who are the decision-makers at Rejuvenation Technologies?
- Fundz holds 2 contacts at Rejuvenation Technologies, including the Co-Founder, CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Rejuvenation Technologies that raised within 45 days of this round, from Fundz verified event records.
- BioVie raised $4.7M (Post-IPO Equity) on November 6, 2026.
- Alethio raised $90M (Series A) on November 5, 2026.
- MyoPax raised an undisclosed amount (Pre-Seed) on November 4, 2026.
- Emvena Therapeutics raised an undisclosed amount (Seed) on November 4, 2026.
- Biograil raised $22M on November 4, 2026.
- Thryv Therapeutics raised $30M (Series B) on November 3, 2026.
Who to call at Rejuvenation Technologies, and when
A new round usually means Rejuvenation Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rejuvenation Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rejuvenation Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rejuvenation Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rejuvenation Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rejuvenation Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.